Stay updated on Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T20:42:54.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T20:52:47.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, showing an access-denied notice instead of the study record content and navigation. This indicates the study page is currently inaccessible.
    Difference
    20%
    Check dated 2026-09-19T22:26:15.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The study page now includes a funding note for 2019 (U.S. NIH Grant/Contract) in the study identifiers, and the revision tag in the page footer has been updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T18:59:46.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    IPD data-sharing details and access criteria were added, along with references to study documents and publications, expanding the available resources and data-access options for the Lebrikizumab trial.
    Difference
    100%
    Check dated 2026-08-15T15:49:54.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5 instead of Revision: v3.6.4, indicating a small platform update to the page's underlying framework. There is no indication of changes to the trial content or study details.
    Difference
    0.0%
    Check dated 2026-08-08T11:43:19.000Z thumbnail image

Stay in the know with updates to Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.